OIEPX
Price
$25.07
Change
+$0.10 (+0.40%)
Updated
Jul 3 closing price
Net Assets
44.51B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

OIEPX vs VVIAX

Header iconOIEPX vs VVIAX Comparison
Open Charts OIEPX vs VVIAXBanner chart's image
JPMorgan Equity Income R3
Price$25.07
Change+$0.10 (+0.40%)
VolumeN/A
Net Assets44.51B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
OIEPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
OIEPX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OIEPX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. OIEPX (44.5B). VVIAX pays higher dividends than OIEPX: VVIAX (2.18) vs OIEPX (1.48). OIEPX was incepted earlier than VVIAX: OIEPX (9 years) vs VVIAX (25 years). OIEPX (0.95) is less costly to investors than VVIAX (0.05). OIEPX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (9.00). OIEPX has a lower initial minimum investment than VVIAX: OIEPX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. OIEPX (8.64). VVIAX return over 5 years is better than : 80.13 vs. OIEPX (64.74).
OIEPXVVIAXOIEPX / VVIAX
Total Expense Ratio0.950.051,900%
Annual Report Gross Expense Ratio0.950.051,900%
Fund Existence9 years25 years-
Gain YTD8.0156.198129%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets44.5B189B24%
Annual Yield % from dividends1.482.1868%
Returns for 1 year8.6412.0372%
Returns for 3 years22.4835.1764%
Returns for 5 years64.7480.1381%
Returns for 10 yearsN/A115.67-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.